Deltaretrovirus infections are primarily associated with the Human T-Cell Lymphotropic Virus (HTLV), a group of retroviruses that predominantly infect T lymphocytes. HTLV is divided into subtypes, with HTLV-1 and HTLV-2 being the most clinically significant. HTLV-1 is linked to various diseases, including Adult T-Cell Leukemia/Lymphoma (ATLL) and a progressive neurological disorder known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Infection occurs through contact with contaminated blood, sexual transmission, and from mother to child through breastfeeding. While the majority of individuals infected with HTLV-1 remain asymptomatic carriers, a subset develops severe complications. Diagnosis involves serological testing and molecular assays. There is no specific antiviral treatment for HTLV-1, and management focuses on treating associated conditions. Prevention strategies include promoting safe sexual practices, avoiding sharing of needles, and discouraging breastfeeding in infected mothers to reduce transmission risk.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation